293 related articles for article (PubMed ID: 22016510)
1. Noninvasive detection of breast cancer lymph node metastasis using carbonic anhydrases IX and XII targeted imaging probes.
Tafreshi NK; Bui MM; Bishop K; Lloyd MC; Enkemann SA; Lopez AS; Abrahams D; Carter BW; Vagner J; Grobmyer SR; Gillies RJ; Morse DL
Clin Cancer Res; 2012 Jan; 18(1):207-19. PubMed ID: 22016510
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
[TBL] [Abstract][Full Text] [Related]
3. Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast.
van Brussel AS; Adams A; Vermeulen JF; Oliveira S; van der Wall E; Mali WP; van Diest PJ; van Bergen En Henegouwen PM
Breast Cancer Res Treat; 2013 Jul; 140(2):263-72. PubMed ID: 23860929
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase IX stratifies patient prognosis and identifies nodal status in animal models of nasopharyngeal carcinoma using a targeted imaging strategy.
Huang W; Wang K; Huang W; He Z; Zhang J; Zhang B; Xiong Z; Gillen KM; Li W; Chen F; Yang X; Zhang S; Tian J
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4427-4439. PubMed ID: 35925443
[TBL] [Abstract][Full Text] [Related]
5. A mammaglobin-A targeting agent for noninvasive detection of breast cancer metastasis in lymph nodes.
Tafreshi NK; Enkemann SA; Bui MM; Lloyd MC; Abrahams D; Huynh AS; Kim J; Grobmyer SR; Carter WB; Vagner J; Gillies RJ; Morse DL
Cancer Res; 2011 Feb; 71(3):1050-9. PubMed ID: 21169406
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models.
Ward C; Meehan J; Mullen P; Supuran C; Dixon JM; Thomas JS; Winum JY; Lambin P; Dubois L; Pavathaneni NK; Jarman EJ; Renshaw L; Um IH; Kay C; Harrison DJ; Kunkler IH; Langdon SP
Oncotarget; 2015 Sep; 6(28):24856-70. PubMed ID: 26259239
[TBL] [Abstract][Full Text] [Related]
7. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C
Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744
[TBL] [Abstract][Full Text] [Related]
8. The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype.
Sousa B; Ribeiro AS; Nobre AR; Lopes N; Martins D; Pinheiro C; Vieira AF; Albergaria A; Gerhard R; Schmitt F; Baltazar F; Paredes J
BMC Cancer; 2014 Oct; 14():734. PubMed ID: 25269858
[TBL] [Abstract][Full Text] [Related]
9. Metabolism-related proteins are differentially expressed according to the molecular subtype of invasive breast cancer defined by surrogate immunohistochemistry.
Choi J; Jung WH; Koo JS
Pathobiology; 2013; 80(1):41-52. PubMed ID: 22832328
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX.
Chen CL; Chu JS; Su WC; Huang SC; Lee WY
Virchows Arch; 2010 Jul; 457(1):53-61. PubMed ID: 20526721
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma.
Chrastina A; Závada J; Parkkila S; Kaluz S; Kaluzová M; Rajcáni J; Pastorek J; Pastoreková S
Int J Cancer; 2003 Jul; 105(6):873-81. PubMed ID: 12767076
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic mechanism and efficacy of the antibody-drug conjugate BAY 79-4620 targeting human carbonic anhydrase 9.
Petrul HM; Schatz CA; Kopitz CC; Adnane L; McCabe TJ; Trail P; Ha S; Chang YS; Voznesensky A; Ranges G; Tamburini PP
Mol Cancer Ther; 2012 Feb; 11(2):340-9. PubMed ID: 22147747
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of metastasis-related genes in hypoxic cells sorted from cervical and lymph nodal xenograft tumors.
Chaudary N; Hill RP
Lab Invest; 2009 May; 89(5):587-96. PubMed ID: 19308047
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of carbonic anhydrase IX (CAIX) in vulvar cancer is associated with tumor progression and development of locoregional lymph node metastases.
Choschzick M; Woelber L; Hess S; zu Eulenburg C; Schwarz J; Simon R; Mahner S; Jaenicke F; Müller V
Virchows Arch; 2010 May; 456(5):483-90. PubMed ID: 20358226
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma.
Chia SK; Wykoff CC; Watson PH; Han C; Leek RD; Pastorek J; Gatter KC; Ratcliffe P; Harris AL
J Clin Oncol; 2001 Aug; 19(16):3660-8. PubMed ID: 11504747
[TBL] [Abstract][Full Text] [Related]
16. [Significance of carbonic anhydrase IX protein expression in molecular subtyping of breast cancers].
Li MP; Ren LF; Cai HG; Yang HY; Lu B; Zhang P; Bao L
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):182-5. PubMed ID: 23769438
[TBL] [Abstract][Full Text] [Related]
17. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.
Trastour C; Benizri E; Ettore F; Ramaioli A; Chamorey E; Pouysségur J; Berra E
Int J Cancer; 2007 Apr; 120(7):1451-8. PubMed ID: 17245699
[TBL] [Abstract][Full Text] [Related]
18. Fibrotic focus and hypoxia in male breast cancer.
Kornegoor R; Verschuur-Maes AH; Buerger H; Hogenes MC; de Bruin PC; Oudejans JJ; Hinrichs B; van Diest PJ
Mod Pathol; 2012 Oct; 25(10):1397-404. PubMed ID: 22684218
[TBL] [Abstract][Full Text] [Related]
19. Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma.
Alper O; Stetler-Stevenson WG; Harris LN; Leitner WW; Ozdemirli M; Hartmann D; Raffeld M; Abu-Asab M; Byers S; Zhuang Z; Oldfield EH; Tong Y; Bergmann-Leitner E; Criss WE; Nagasaki K; Mok SC; Cramer DW; Karaveli FS; Goldbach-Mansky R; Leo P; Stromberg K; Weil RJ
Cancer Sci; 2009 Sep; 100(9):1748-56. PubMed ID: 19594548
[TBL] [Abstract][Full Text] [Related]
20. Dynamic surveillance of tamoxifen-resistance in ER-positive breast cancer by CAIX-targeted ultrasound imaging.
Li Y; Chen X; Zhou Z; Li Q; Westover KD; Wang M; Liu J; Zhang S; Zhang J; Xu B; Wei X
Cancer Med; 2020 Apr; 9(7):2414-2426. PubMed ID: 32048471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
